The Babraham Research Campus is home to over 60 bioscience organisations and the world renowned Babraham Institute. The current success of the Campus is underpinned by a shared focus in the science and innovation themes undertaken by the companies and academic researchers on site. The Campus research community is delivering research and innovation with a focus on key questions in biology that resonate with the Campus’ commercial community, with global investors, and society more widely. Want to be part of this innovative, exciting community? Explore current vacancies below:
22 September 2023
The Babraham Investor Conference 2023 (BIC) saw more than 150 company founders, investors and industry leaders come together at Babraham Research Campus yesterday, Thursday 21st September.
22 September 2023
Today, Maxion Therapeutics announced the appointment of senior industry leader Eva-Lotta Allan as the Chair of its Board of Directors.
21 September 2023
Cementing its position as one of the best places to start-up and scale-up a life sciences venture in Europe, Babraham Research Campus today announced the launch of its new LiveLabs initiative.
Building on the online-only format developed over the past two years, the Babraham Investor Conference 2022 (BIC) returned to a full-scale, hybrid event in June after the pandemic transformed how the event is delivered. The must-attend event for investors featured an afternoon of rich presentations from a selection of guest speakers and start-up and scale-up companies, beginning with with a keynote from Sir Harpal Kumar, President of GRAIL Europe, in conversation with Dr Andy Richards.